Sarozar
Saroglitazar is a Dual Peroxisome Proliferator-Activated Receptor (PPAR) of and agonist used for the treatment of Nonalcoholic Fatty Liver Disease (NAFLD), Dyslipidemia and Primary Biliary Cholangitis (PBC).
Features
| Product Name | Sarozar |
| Generic Name | Saroglitazar |
| Therapeutic Class | Dual Peroxisome Proliferator-Activated Receptor (PPAR) of alpha and gamma agonist |
| Formulation | Solid |
| Available Pack Size | 3 X 10 |
| Available Strength | 2 mg |